Instil Bio, Inc. TIL
6.83 USD -0.16 (-2.29%)
At closeNov 6, 2026, 4:00 PM EST
6.83 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
6.30 Day range 6.98
5.57 52-week range 15.75
- YTD
- -37.91%
- 1 year
- -54.53%
News
benzinga.com Instil Bio Q2 Adj. EPS $(0.45) Misses $(0.43) Estimate Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 84.37 percent increase over losses of $(2.88)…
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session 
benzinga.com Earnings Scheduled For May 15, 2026 - benzinga.com Earnings Scheduled For March 27, 2026
benzinga.com Instil Bio Q4 Adj. EPS $(0.97) Beats $(2.03) Estimate Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.97) per share which beat the analyst consensus estimate of $(2.03) by 52.15 percent. This is a 10.19 percent increase over losses of $(1.08)…
benzinga.com Dow Jumps Over 400 Points; US Services Activity Falls In December 
benzinga.com Instil Bio Pulls Plug On Lead Drug Development Instil Bio stock falls after the company ends development of its lead cancer drug and exits a licensing deal, raising new questions about its pipeline and next steps.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session 
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points - benzinga.com Instil Bio Q3 Adj. EPS $(1.75) Beats $(2.35) Estimate Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.75) per share which beat the analyst consensus estimate of $(2.35) by 25.69 percent. This is a 31.37 percent increase over losses of $(2.55)…
- benzinga.com HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price target.
benzinga.com Instil Bio Says ImmuneOnco Biopharma Presents Preliminary Efficacy And Safety Data Of '2510 As Monotherapy In Phase 1 Study Of Patients In China With Previously Treated Sq-NSCLC At 2025 WCLC ORR of 35% in previously treated squamous NSCLC patients with responses across PD-L1 TPS scoresDifferentiated structure of ‘2510 potentially results in best-in-class monotherapy activity in 2L+ NSCLC…- benzinga.com HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price target.
benzinga.com HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price target.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $125 Price Target HC Wainwright & Co. analyst Mitchell Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $125 price target.
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session - benzinga.com JMP Securities Reiterates Market Perform on Instil Bioto Market Perform JMP Securities analyst Reni Benjamin reiterates Instil Bio (NASDAQ:TIL) from Market Perform to Market Perform.
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com HC Wainwright & Co. Maintains Buy on Instil Bio, Lowers Price Target to $105 HC Wainwright & Co. analyst Mitchell Kapoor maintains Instil Bio (NASDAQ:TIL) with a Buy and lowers the price target from $110 to $105.
- benzinga.com Instil Bio, ImmuneOnco Advance Lung Cancer Drug '2510 With New Trials in China and US Plans Ahead Instil Bio, Inc. (NASDAQ:TIL, ", Instil", ))) and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, "ImmuneOnco"), today announced clinical trial updates of ‘2510 and NSCLC clinical…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Pegasystems Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket 
benzinga.com Instil Bio Q1 Adj. EPS $(1.32) Beats $(2.59) Estimate Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.32) per share which beat the analyst consensus estimate of $(2.59) by 49.03 percent. This is a 44.77 percent increase over losses of $(2.39)…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
- benzinga.com HC Wainwright & Co. Reiterates Buy on Instil Bio, Maintains $110 Price Target HC Wainwright & Co. analyst Mitchell Kapoor reiterates Instil Bio (NASDAQ:TIL) with a Buy and maintains $110 price target.
benzinga.com Instil Bio Q4 2024 GAAP EPS $(1.82) Beats $(3.22) Estimate, Instil Had $115.1M In Total Cash, Cash Equivalents, Restricted Cash And Marketable Securities, That Is Expected To Fund Its Current Operating Plan Beyond 2026 Instil Bio (NASDAQ:TIL) reported quarterly losses of $(1.82) per share which beat the analyst consensus estimate of $(3.22) by 43.48 percent. This is a 8.54 percent increase over losses of $(1.99)…- benzinga.com JMP Securities Reiterates Market Perform on Instil Bioto Market Perform JMP Securities analyst Chris Muller reiterates Instil Bio (NASDAQ:TIL) from Market Perform to Market Perform.
- benzinga.com Instil Bio Announces Clinical Progress In China For IMM2510/SYN-2510, A Clinical-Stage PD-L1xVEGF Bispecific Antibody ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China.
- benzinga.com Sky Harbour Group, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- benzinga.com iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
benzinga.com Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 325 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday OnFriday, 143 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 298 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 241 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Monday saw 196 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's trading, 138 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 167 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 72 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 64 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday OnThursday, 137 stocks made new 52-week lows.
- benzinga.com Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday Gainers
- benzinga.com Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
- benzinga.com Goodyear Tire, Catalent, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Tuesday. Here are some big stocks recording losses in today’s session.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 96 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 807 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 1043 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's trading, 435 companies set new 52-week lows.